Isar Aerospace Secures $270 Million in Latest Series D Funding Round

Isar Aerospace secured $270 million in its latest Series D, adding another data point to the Healthcare & Life Sciences funding market.

Isar Aerospace Raises $270 million in Funding

Isar Aerospace closes €270 million Series D as Europe races to end its dependence on SpaceX. The Munich rocket startup is backed by Island Green Capital and Molten Ventures as it prepares a qualification orbital launch from Norway's Andøya Spaceport, still pending after multiple scrubs.

Investors Behind the Funding

The round was backed by Island Green Capital. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Isar Aerospace operates in Healthcare & Life Sciences. Isar Aerospace's financing adds to recent private-market activity.

Strategic Use of Funds

End its dependence on SpaceX.

Looking Ahead

Isar Aerospace closes €270 million Series D as Europe races to end its dependence on SpaceX

Source reference: original announcement/article.